Entitlement Offer Results and Shortfall Announcement

Optiscan ASX cap raise result web

We are pleased to announce our Entitlement Issue has successfully raised a total of $16.7m in funds, with $8.8m from Entitlement applications and $7.9m allocated to underwriters.

This funding enables us to pursue R&D projects for rigid and flexible surgical applications, enhance core image capture capability, and advance artificial intelligence and telepathology service solutions. We will also conduct clinical studies to meet FDA requirements and develop new clinical devices.

Read more here

Select Category